| Mar'20 | Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 |
|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||
6,998 | 6,522 | 4,865 | 5,389 | 5,462 | 4,940 | 2,541 | 1,874 | 1,528 |
Operating expenses | ||||||||
Research and development | ||||||||
24,879 | 19,904 | 19,791 | 22,760 | 19,961 | 16,399 | 9,737 | 10,869 | 8,117 |
General and administrative | ||||||||
9,615 | 8,479 | 7,052 | 6,500 | 4,995 | 4,646 | 3,251 | 3,130 | 2,646 |
Total operating expenses | ||||||||
34,494 | 28,383 | 26,843 | 29,260 | 24,956 | 21,045 | 12,988 | 13,999 | 10,763 |
Loss from operations | ||||||||
-27,496 | -21,861 | -21,978 | -23,871 | -19,494 | -16,105 | -10,447 | -12,125 | -9,235 |
Other income (expense), net: | ||||||||
Change in fair value of convertible notes payable | ||||||||
- | 0 | 0 | -2,950 | 12,708 | - | - | - | - |
Interest expense | ||||||||
- | 0 | 0 | 0 | 182 | - | - | - | - |
Interest income | ||||||||
660 | 945 | 1,236 | 1,485 | 601 | 662 | 691 | 299 | 223 |
Total other income (expense), net | ||||||||
660 | 945 | 1,236 | 4,435 | -12,289 | 662 | 691 | 299 | 223 |
Net loss and net loss attributable to common stockholders | ||||||||
-26,836 | -20,916 | -20,742 | -19,436 | -31,783 | -15,443 | -9,756 | -11,826 | -9,012 |
Net loss per share attributable to common stockholders- basic and diluted | ||||||||
-0.52 | 0.58 | -0.41 | -0.39 | -1.99 | -0.98 | -0.62 | -0.75 | -0.57 |
Weighted average shares of common stock outstanding- basic and diluted | ||||||||
51,312 | 51,338 | 50,623 | 50,035 | 15,967 | 15,850 | 15,816 | 15,730 | 15,704 |